India, Feb. 4 -- Tonix Pharmaceuticals Holding Corp. (TNXP) Tuesday announced that it has promoted Siobhan Fogarty to Chief Technical Officer, effective immediately.
Fogarty, who joined the company in 2016, previously served as Executive Vice President of Product Development.
The company awaits the FDA's decision on August 15, 2025, regarding TNX-102 SL, a non-opioid therapy for fibromyalgia.
TNXP is currently trading at $0.15, down 18.22 percent or $0.035 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....